RSS   Newsletter   Contact   Advertise with us
Post Online Media

KalVista Pharma appoints Andreas Maetzel as SVP

KalVista PharmaKalVista Pharmaceuticals, a clinical stage pharmaceutical company, announced the appointment of Andreas Maetzel to the role of senior vice president, medical.
Dr. Maetzel was most recently Vice President, Global Medical Affairs at BioCryst Pharmaceuticals.

Prior to that he was Vice President, Clinical Development & Regulatory Affairs at Cornerstone Therapeutics Inc.

Previously, Dr. Maetzel held a clinical development role at BioCryst, and also positions in strategy consulting and at Amgen.

Dr. Maetzel is a Visiting Scientist, Faculty of Medicine, University Hospital Zurich and Charité Hospital Berlin, and Adjunct Professor, Institute for Health Policy, Management & Evaluation, University of Toronto.

Dr. Maetzel obtained both a Ph.D and M.Sc. in Clinical Epidemiology from the University of Toronto and a Dr. med. at the University of Hannover, Germany. â– 

 

 LATEST MOVES FROM Massachusetts 


 
 

POST Online Media does not use cookies to collect information about visitors.   OK, hide this message   Third party ads may be using cookies, you can see how here.